1. Home
  2. ARGX
  3. ARGX News

Latest argenx SE (ARGX) News on September 17, 2025

ARGX

MT Newswires

a day ago

European Equities Traded in the US as American Depositary Receipts Edge Lower in Tuesday Trading

argenx SE (ARGX) Expands Autoimmune Leadership with Vyvgart Launch
ARGX

Insider Monkey

6 days ago

argenx SE (ARGX) Expands Autoimmune Leadership with Vyvgart Launch

Why Dianthus Therapeutics, Up 47% In Four Weeks, Just Surged Again
ARGX

Investor's Business Daily

9 days ago

Why Dianthus Therapeutics, Up 47% In Four Weeks, Just Surged Again

A Closer Look at argenx (ENXTBR:ARGX) Valuation Following Positive VYVGART Study Results and Label Expansion Plans
ARGX

Simply Wall St.

9 days ago

A Closer Look at argenx (ENXTBR:ARGX) Valuation Following Positive VYVGART Study Results and Label Expansion Plans

ARGX

MT Newswires

13 days ago

Immunovant's New Data Shows Batoclimab's Potential to Replace Current Graves' Disease Options, Oppenheimer Says

ARGX

MT Newswires

13 days ago

European Equities Traded in the US as American Depositary Receipts Rise in Thursday Trading

ARGX

Morningstar Research

14 days ago

Analyst Report: argenx SE

Hemab Therapeutics Expands Leadership with Appointment of Anant Murthy, PhD, as Chief Operating Officer
ARGX

PR Newswire

15 days ago

Hemab Therapeutics Expands Leadership with Appointment of Anant Murthy, PhD, as Chief Operating Officer

KMDA or ARGX: Which Is the Better Value Stock Right Now?
ARGX

Zacks

16 days ago

KMDA or ARGX: Which Is the Better Value Stock Right Now?

argenx to Present at Upcoming Investor Conferences
ARGX

GlobeNewswire

21 days ago

argenx to Present at Upcoming Investor Conferences

Argenx Stock Hits Record High After Reporting 664% Earnings Surge; This Rating Upgraded
ARGX

Investor's Business Daily

22 days ago

Argenx Stock Hits Record High After Reporting 664% Earnings Surge; This Rating Upgraded

Argenx Immune Disorder Drug's Reach Could Get Much Bigger With Major Trial Win
ARGX

Benzinga

22 days ago

Argenx Immune Disorder Drug's Reach Could Get Much Bigger With Major Trial Win

ARGX

MT Newswires

22 days ago

European Equities Traded in the US as American Depositary Receipts Track Lower in Tuesday Trading

ARGX

MT Newswires

23 days ago

European Equities Traded in the US as American Depositary Receipts Start Week Lower in Monday Trading

Figma initiated, Okta upgraded: Wall Street's top analyst calls
ARGX

The Fly

23 days ago

Figma initiated, Okta upgraded: Wall Street's top analyst calls

ARGX

MT Newswires

23 days ago

Sector Update: Health Care Stocks Flat to Lower Pre-Bell Monday

Argenx Tops Buy Point On Bullish Study, 850 Price Target
ARGX

Investor's Business Daily

23 days ago

Argenx Tops Buy Point On Bullish Study, 850 Price Target

Argenx Targets FDA Label Expansion After Vyvgart Trial Success
ARGX

Benzinga

23 days ago

Argenx Targets FDA Label Expansion After Vyvgart Trial Success

ARGX

MT Newswires

23 days ago

Exchange-Traded Funds, Equity Futures Lower Pre-Bell Monday Ahead of Economic Data

ARGX

MT Newswires

23 days ago

RBC Initiates Argenx at Outperform With $850 Price Target

argenx Announces Positive Topline Results from ADAPT SERON Study of VYVGART in Patients with AChR-Ab Seronegative gMG
ARGX

GlobeNewswire

24 days ago

argenx Announces Positive Topline Results from ADAPT SERON Study of VYVGART in Patients with AChR-Ab Seronegative gMG

argenx to Host R&D Webinar Highlighting ARGX-119 on September 16, 2025
ARGX

GlobeNewswire

a month ago

argenx to Host R&D Webinar Highlighting ARGX-119 on September 16, 2025

ARGX

Morningstar Research

a month ago

Analyst Report: argenx SE

ARGX

MT Newswires

a month ago

European Equities Traded in the US as American Depositary Receipts Start Week Slightly Lower in Monday Trading

High Growth Tech Stocks Featuring Global and Two More with Promising Growth
ARGX

Simply Wall St.

a month ago

High Growth Tech Stocks Featuring Global and Two More with Promising Growth

argenx SE (ARGX): A Bull Case Theory
ARGX

Insider Monkey

a month ago

argenx SE (ARGX): A Bull Case Theory

How Argenx's 'Blowout' Quarter Sparked A Blazing 31% Monthlong Run
ARGX

Investor's Business Daily

a month ago

How Argenx's 'Blowout' Quarter Sparked A Blazing 31% Monthlong Run

ARGX

MT Newswires

a month ago

European Equities Traded in the US as American Depositary Receipts Edge Lower in Friday Trading

High Growth Tech Stocks In Europe To Watch June 2025
ARGX

Simply Wall St.

3 months ago

High Growth Tech Stocks In Europe To Watch June 2025

Exploring High Growth Tech Stocks In Europe June 2025
ARGX

Simply Wall St.

3 months ago

Exploring High Growth Tech Stocks In Europe June 2025

High Growth Tech Stocks In Europe Featuring Ubisoft Entertainment And Two Others
ARGX

Simply Wall St.

3 months ago

High Growth Tech Stocks In Europe Featuring Ubisoft Entertainment And Two Others

Argenx Secures EC Approval for Subcutaneous VYVGART in CIDP Treatment
ARGX

Insider Monkey

3 months ago

Argenx Secures EC Approval for Subcutaneous VYVGART in CIDP Treatment

High Growth Tech Stocks To Watch In June 2025
ARGX

Simply Wall St.

3 months ago

High Growth Tech Stocks To Watch In June 2025

argenx Announces European Commission Approval of VYVGART Subcutaneous Injection for Chronic Inflammatory Demyelinating Polyneuropathy
ARGX

GlobeNewswire

3 months ago

argenx Announces European Commission Approval of VYVGART Subcutaneous Injection for Chronic Inflammatory Demyelinating Polyneuropathy

High Growth Tech Stocks in Europe for June 2025
ARGX

Simply Wall St.

3 months ago

High Growth Tech Stocks in Europe for June 2025

High Growth Tech Stocks In Europe To Watch
ARGX

Simply Wall St.

3 months ago

High Growth Tech Stocks In Europe To Watch

argenx Presents New Efgartigimod Data at EULAR 2025 Highlighting Positive Phase 2 Proof-of-Concept Results in Myositis and Sjogren’s Disease
ARGX

GlobeNewswire

3 months ago

argenx Presents New Efgartigimod Data at EULAR 2025 Highlighting Positive Phase 2 Proof-of-Concept Results in Myositis and Sjogren’s Disease

High Growth Tech Stocks To Watch In Europe June 2025
ARGX

Simply Wall St.

3 months ago

High Growth Tech Stocks To Watch In Europe June 2025

argenx SE (ARGX): A Bull Case Theory
ARGX

Insider Monkey

3 months ago

argenx SE (ARGX): A Bull Case Theory

This IBD 50 Biotech's Got 'Rhythm' — And Flashes 3 Telltale Clues
ARGX

Investor's Business Daily

3 months ago

This IBD 50 Biotech's Got 'Rhythm' — And Flashes 3 Telltale Clues

Nurix Therapeutics (NRIX) Moves 14.2% Higher: Will This Strength Last?
ARGX

Zacks

3 months ago

Nurix Therapeutics (NRIX) Moves 14.2% Higher: Will This Strength Last?

argenx to Present at Goldman Sachs 46th Annual Global Healthcare Conference
ARGX

GlobeNewswire

3 months ago

argenx to Present at Goldman Sachs 46th Annual Global Healthcare Conference

Argenx added to Best Ideas List at Wedbush
ARGX

TipRanks

4 months ago

Argenx added to Best Ideas List at Wedbush

argenx Announces Results of Annual General Meeting of Shareholders
ARGX

GlobeNewswire

4 months ago

argenx Announces Results of Annual General Meeting of Shareholders

ARGX

MT Newswires

4 months ago

Argenx Set to See Further Growth Due to Vyvgart Momentum, Pipeline Expansion, Wedbush Says

argenx SE (ARGX): Among the Best Growth Stocks to Buy and Hold for the Long Term
ARGX

Insider Monkey

4 months ago

argenx SE (ARGX): Among the Best Growth Stocks to Buy and Hold for the Long Term

Argenx (ARGX) Upgraded to Buy: Here's Why
ARGX

Zacks

4 months ago

Argenx (ARGX) Upgraded to Buy: Here's Why

ARGX

Morningstar Research

4 months ago

Analyst Report: argenx SE

argenx SE (ARGX): Among the Best Cancer Stocks to Invest in for Long-Term Gain
ARGX

Insider Monkey

4 months ago

argenx SE (ARGX): Among the Best Cancer Stocks to Invest in for Long-Term Gain

argenx SE (ARGX) Q1 2025 Earnings Call Highlights: Record Growth and Strategic Advances
ARGX

GuruFocus.com

4 months ago

argenx SE (ARGX) Q1 2025 Earnings Call Highlights: Record Growth and Strategic Advances

ARGX

MT Newswires

4 months ago

Sector Update: Health Care Stocks Decline Pre-Bell Thursday

Argenx Beats Sales Expectations — But Not By Enough — And Shares Tumble
ARGX

Investor's Business Daily

4 months ago

Argenx Beats Sales Expectations — But Not By Enough — And Shares Tumble

ARGX

MT Newswires

4 months ago

Argenx Reports Q1 Earnings, Higher Operating Income; Shares Down Pre-Bell

argenx Reports First Quarter 2025 Financial Results and Provides Business Update
ARGX

GlobeNewswire

4 months ago

argenx Reports First Quarter 2025 Financial Results and Provides Business Update

argenx SE (ARGX): A Bull Case Theory
ARGX

Insider Monkey

4 months ago

argenx SE (ARGX): A Bull Case Theory

argenx to Present at BofA Securities 2025 Health Care Conference
ARGX

GlobeNewswire

4 months ago

argenx to Present at BofA Securities 2025 Health Care Conference

Is argenx SE (ARGX) the Most Profitable Growth Stock to Buy Now?
ARGX

Insider Monkey

5 months ago

Is argenx SE (ARGX) the Most Profitable Growth Stock to Buy Now?

Exploring High Growth Tech Stocks In Europe
ARGX

Simply Wall St.

5 months ago

Exploring High Growth Tech Stocks In Europe

argenx to Report First Quarter 2025 Financial Results and Business Update on May 8, 2025
ARGX

GlobeNewswire

5 months ago

argenx to Report First Quarter 2025 Financial Results and Business Update on May 8, 2025

Argenx Stock Extends Rally In A Base As Earnings Loom
ARGX

Investor's Business Daily

5 months ago

Argenx Stock Extends Rally In A Base As Earnings Loom

ARGX

MT Newswires

5 months ago

Argenx Gets Positive Committee Opinion in Europe for Autoimmune Disorder Treatment

argenx Announces Positive CHMP Opinion for VYVGART (efgartigimod alfa) Subcutaneous Injection for Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
ARGX

GlobeNewswire

5 months ago

argenx Announces Positive CHMP Opinion for VYVGART (efgartigimod alfa) Subcutaneous Injection for Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)

Argenx (ARGX) Moves 4.4% Higher: Will This Strength Last?
ARGX

Zacks

5 months ago

Argenx (ARGX) Moves 4.4% Higher: Will This Strength Last?

Is Argenx SE (ARGX) the Best Growth Stock to Buy According to Billionaires?
ARGX

Insider Monkey

5 months ago

Is Argenx SE (ARGX) the Best Growth Stock to Buy According to Billionaires?

FDA Approves Argenx's Vyvgart Hytrulo Prefilled Syringe For Self-Injection For At Home Use Setting
ARGX

Benzinga

5 months ago

FDA Approves Argenx's Vyvgart Hytrulo Prefilled Syringe For Self-Injection For At Home Use Setting

argenx Announces Annual General Meeting of Shareholders on May 27, 2025
ARGX

GlobeNewswire

5 months ago

argenx Announces Annual General Meeting of Shareholders on May 27, 2025

Argenx Bounds Off 200-Day Line On 'Best-Case Scenario' For Blockbuster Drug
ARGX

Investor's Business Daily

5 months ago

Argenx Bounds Off 200-Day Line On 'Best-Case Scenario' For Blockbuster Drug

ARGX

MT Newswires

5 months ago

Halozyme Therapeutics Reports FDA Approval for Self-Injectable Syringe Developed in Partnership With Argenx

argenx Announces FDA Approval of VYVGART Hytrulo Prefilled Syringe for Self-Injection in Generalized Myasthenia Gravis and Chronic Inflammatory Demyelinating Polyneuropathy
ARGX

GlobeNewswire

5 months ago

argenx Announces FDA Approval of VYVGART Hytrulo Prefilled Syringe for Self-Injection in Generalized Myasthenia Gravis and Chronic Inflammatory Demyelinating Polyneuropathy

argenx SE (ARGX): Among the Aggressive Stocks Picked by Hedge Funds
ARGX

Insider Monkey

5 months ago

argenx SE (ARGX): Among the Aggressive Stocks Picked by Hedge Funds

Argenx's Flagship Drug Vyvgart Shows Sustained Disease Control In Rare Neuromuscular Disease Patients
ARGX

Benzinga

5 months ago

Argenx's Flagship Drug Vyvgart Shows Sustained Disease Control In Rare Neuromuscular Disease Patients

argenx Highlights VYVGART Data at AAN 2025 Setting New Standard in Sustained Efficacy and Improved Quality of Life Measures for Patients Living with gMG and CIDP
ARGX

GlobeNewswire

5 months ago

argenx Highlights VYVGART Data at AAN 2025 Setting New Standard in Sustained Efficacy and Improved Quality of Life Measures for Patients Living with gMG and CIDP

Is Argenx SE (ARGX) The Most Profitable Biotech Stock To Buy Right Now?
ARGX

Insider Monkey

5 months ago

Is Argenx SE (ARGX) The Most Profitable Biotech Stock To Buy Right Now?

Exploring Three High Growth Tech Stocks in Europe
ARGX

Simply Wall St.

5 months ago

Exploring Three High Growth Tech Stocks in Europe

Argenx (ARGX) Surges 4.1%: Is This an Indication of Further Gains?
ARGX

Zacks

6 months ago

Argenx (ARGX) Surges 4.1%: Is This an Indication of Further Gains?

Artisan Small Cap Fund Sold argenx SE (ARGX) as it Exceeded Small-Cap Mandate
ARGX

Insider Monkey

6 months ago

Artisan Small Cap Fund Sold argenx SE (ARGX) as it Exceeded Small-Cap Mandate

argenx Highlights FcRn Leadership with Long-term Data and Transformational Patient Outcomes at the American Academy of Neurology 2025 Annual Meeting
ARGX

GlobeNewswire

6 months ago

argenx Highlights FcRn Leadership with Long-term Data and Transformational Patient Outcomes at the American Academy of Neurology 2025 Annual Meeting

Biohaven Slumps, Again, As Bipolar Setback Outweighs A $4 Billion Opportunity
ARGX

Investor's Business Daily

6 months ago

Biohaven Slumps, Again, As Bipolar Setback Outweighs A $4 Billion Opportunity

ARGX

Morningstar Research

7 months ago

Analyst Report: argenx SE

ARGX

MT Newswires

7 months ago

Argenx's Q4 Sales Backed by Vyvgart's Growth, Oppenheimer Says

Exploring 3 High Growth Tech Stocks in Europe
ARGX

Simply Wall St.

7 months ago

Exploring 3 High Growth Tech Stocks in Europe

ARGX

MT Newswires

7 months ago

Argenx Q4 Swings to Earnings, Operating Income Increases

argenx Reports Full Year 2024 Financial Results and Provides Fourth Quarter Business Update
ARGX

GlobeNewswire

7 months ago

argenx Reports Full Year 2024 Financial Results and Provides Fourth Quarter Business Update

argenx to Present at TD Cowen 45th Annual Healthcare Conference
ARGX

GlobeNewswire

7 months ago

argenx to Present at TD Cowen 45th Annual Healthcare Conference

These Biotech Stocks Aren't Profitable But Still Make Elite IBD 50
ARGX

Investor's Business Daily

7 months ago

These Biotech Stocks Aren't Profitable But Still Make Elite IBD 50

argenx to Report Full Year 2024 Financial Results and Fourth Quarter Business Update on February 27, 2025
ARGX

GlobeNewswire

7 months ago

argenx to Report Full Year 2024 Financial Results and Fourth Quarter Business Update on February 27, 2025

Here’s Why argenx SE (ARGX) Rose in Q4
ARGX

Insider Monkey

7 months ago

Here’s Why argenx SE (ARGX) Rose in Q4

ARGX

Thomson Reuters StreetEvents

7 months ago

Q4 2024 Halozyme Therapeutics Inc Earnings Call

Is Argenx (ARGX) Outperforming Other Medical Stocks This Year?
ARGX

Zacks

8 months ago

Is Argenx (ARGX) Outperforming Other Medical Stocks This Year?

Exploring High Growth Tech Stocks With Promising Potential
ARGX

Simply Wall St.

8 months ago

Exploring High Growth Tech Stocks With Promising Potential

Is argenx SE (ARGX) the High Growth International Stock to Invest in Now?
ARGX

Insider Monkey

8 months ago

Is argenx SE (ARGX) the High Growth International Stock to Invest in Now?

Is Ascendis Pharma (ASND) the High Growth International Stock to Invest in Now?
ARGX

Insider Monkey

8 months ago

Is Ascendis Pharma (ASND) the High Growth International Stock to Invest in Now?

Earnings Estimates Rising for Argenx (ARGX): Will It Gain?
ARGX

Zacks

8 months ago

Earnings Estimates Rising for Argenx (ARGX): Will It Gain?

argenx Highlights 2025 Strategic Priorities
ARGX

GlobeNewswire

8 months ago

argenx Highlights 2025 Strategic Priorities

argenx to Present at 43rd Annual J.P. Morgan Healthcare Conference
ARGX

GlobeNewswire

8 months ago

argenx to Present at 43rd Annual J.P. Morgan Healthcare Conference

Exploring High Growth Tech Stocks for January 2025
ARGX

Simply Wall St.

9 months ago

Exploring High Growth Tech Stocks for January 2025

Argenx Secures Japanese Approval for VYVDURA in CIDP Treatment
ARGX

TipRanks

9 months ago

Argenx Secures Japanese Approval for VYVDURA in CIDP Treatment

ARGX

MT Newswires

9 months ago

Wedbush Raises Argenx's Price Target to $665 From $655, Maintains Outperform Rating

ARGX

MT Newswires

9 months ago

Argenx Says Japan Approves Vyvdura Injection for Chronic Inflammatory Demyelinating Polyneuropathy

argenx Announces Approval of VYVDURA (efgartigimod alfa and hyaluronidase-qvfc) in Japan for Adults with Chronic Inflammatory Demyelinating Polyneuropathy
ARGX

GlobeNewswire

9 months ago

argenx Announces Approval of VYVDURA (efgartigimod alfa and hyaluronidase-qvfc) in Japan for Adults with Chronic Inflammatory Demyelinating Polyneuropathy

Share on Social Networks: